Business Description
Utah Medical Products Inc
NAICS : 339112
SIC : 3841
Description
Utah Medical Products Inc is involved in the business of developing, manufacturing and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 179.96 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 24.6 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.2 | |||||
| 3-Year EBITDA Growth Rate | 7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -6.5 | |||||
| 3-Year FCF Growth Rate | 8.8 | |||||
| 3-Year Book Growth Rate | 7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.6 | |||||
| 9-Day RSI | 39.41 | |||||
| 14-Day RSI | 42.08 | |||||
| 6-1 Month Momentum % | 2.27 | |||||
| 12-1 Month Momentum % | -1.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.79 | |||||
| Quick Ratio | 16.13 | |||||
| Cash Ratio | 14.92 | |||||
| Days Inventory | 127.09 | |||||
| Days Sales Outstanding | 36.19 | |||||
| Days Payable | 19.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.35 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | -7.6 | |||||
| Forward Dividend Yield % | 1.36 | |||||
| 5-Year Yield-on-Cost % | 1.2 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.2 | |||||
| Operating Margin % | 38.66 | |||||
| Net Margin % | 31.18 | |||||
| ROE % | 14.76 | |||||
| ROA % | 13.58 | |||||
| ROIC % | 31.84 | |||||
| ROC (Joel Greenblatt) % | 107.33 | |||||
| ROCE % | 17.55 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.58 | |||||
| PE Ratio without NRI | 19.58 | |||||
| Shiller PE Ratio | 21.21 | |||||
| Price-to-Owner-Earnings | 19.93 | |||||
| PEG Ratio | 3.7 | |||||
| PS Ratio | 6.1 | |||||
| PB Ratio | 2.88 | |||||
| Price-to-Tangible-Book | 3.82 | |||||
| Price-to-Free-Cash-Flow | 15.56 | |||||
| Price-to-Operating-Cash-Flow | 14.97 | |||||
| EV-to-EBIT | 12.29 | |||||
| EV-to-EBITDA | 9.02 | |||||
| EV-to-Revenue | 4.75 | |||||
| EV-to-FCF | 12.13 | |||||
| Price-to-Projected-FCF | 1.38 | |||||
| Price-to-Median-PS-Value | 0.95 | |||||
| Price-to-Graham-Number | 1.83 | |||||
| Price-to-Net-Current-Asset-Value | 4.4 | |||||
| Price-to-Net-Cash | 5.37 | |||||
| Earnings Yield (Greenblatt) % | 8.14 | |||||
| Forward Rate of Return (Yacktman) % | 9.11 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:UTMD
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 51.237 | ||
| EPS (TTM) ($) | 4.357 | ||
| Beta | 0 | ||
| Volatility % | 23.39 | ||
| 14-Day RSI | 42.08 | ||
| 14-Day ATR ($) | 2.695576 | ||
| 20-Day SMA ($) | 87.7265 | ||
| 12-1 Month Momentum % | -1.01 | ||
| 52-Week Range ($) | 80.1 - 133.87 | ||
| Shares Outstanding (Mil) | 3.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Utah Medical Products Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Utah Medical Products Inc Analysis
Share your researchHeadlines
See More
No news.